Vancouver, Canada · Founded 2018 · Privately Held (backing)
Developer of novel metallotherapeutics metal-based small molecules designed for the treatment of cancer. Bold Therapeutics is based in Vancouver, Canada and was founded in 2018. Its last known valuation is $140 million. It has raised $25 million across 1 recorded round; the latest was a $5.5 million early-stage round in Jul 2018.
Last price · $/share
—
Implied valuation
$140.0M
Total raised
$25.0M
Last round
Early Stage VC
Jul 2018
Team — not yet on record
No current team members for Bold Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bold Therapeutics with a free account
·Watch Bold Therapeutics: the Monday email on marks, rounds and moves
